Concepedia

Rachel Laskey

RL

Statistics

Publications

25

Citations

1.6K

H-Index

21

Active since

1989

Affiliations

Pfizer (United States)(Current)

New York University

San Francisco General Hospital

University of Miami

Amsterdam UMC Location University of Amsterdam

Rachel Laskey is an author at Pfizer (United States) specializing in cardiovascular disease, cardiology, and lipid-lowering therapy.

Publications per year

1989–2020

25

Publications

25

Body-Weight Fluctuations and Outcomes in Coronary Disease

Sripal Bangalore, Rana Fayyad, Rachel Laskey et al. · New England Journal of Medicine · 2017 · 314 citations · Full text

, , +17

Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels

Matti J. Tikkanen, Rana Fayyad, Anders Olsson et al. · International Journal of Cardiology · 2013 · 157 citations

, , +10

Membrane potential and Na(+)-K+ pump activity modulate resting and bradykinin-stimulated changes in cytosolic free calcium in cultured endothelial cells from bovine atria.

Rachel Laskey, David J. Adams, A. Johns et al. · Journal of Biological Chemistry · 1990 · 123 citations · Full text

, , +16

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease

Sripal Bangalore, Rana Fayyad, Rachel Laskey et al. · The American Journal of Medicine · 2013 · 91 citations · Full text

, , +14

Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial

Sripal Bangalore, Rana Fayyad, Franz H. Messerli et al. · The American Journal of Cardiology · 2016 · 82 citations

, , +15

1–5 of 25